Analyst Ratings For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Today, Canaccord Genuity reiterated its Buy rating on NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) with a price target of $41.00 ➝ $45.00.
Some recent analyst ratings include
- 6/4/2018-Canaccord Genuity Reiterated Rating of Buy.
- 3/8/2018-Piper Jaffray Companies Reiterated Rating of Hold.
- 1/8/2018-Barclays Reiterated Rating of Sell.
- 12/20/2017-William Blair was Downgraded by analysts at William Blair from a “Outperform ➝ Market Perform” rating to a “” rating.
- 12/13/2017-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Neutral ➝ Underweight” rating to a “” rating. They now have a $25.00 price target on the stock.
- 10/20/2017-Jefferies Group Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) has insider ownership of 45.80% and institutional ownership of 89.90%.
- On 5/14/2018 Kimberly J. Popovits, CEO, sold 10,000 with an average share price of $38.09 per share and the total transaction amounting to $380,900.00.
- On 5/9/2018 Steven Shak, Insider, sold 5,500 with an average share price of $36.64 per share and the total transaction amounting to $201,520.00.
- On 5/2/2018 James J. Vaughn, Insider, sold 1,497 with an average share price of $32.50 per share and the total transaction amounting to $48,652.50.
- On 4/16/2018 Kimberly J. Popovits, Insider, sold 15,000 with an average share price of $33.19 per share and the total transaction amounting to $497,850.00.
- On 3/13/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.80 per share and the total transaction amounting to $164,000.00.
- On 2/20/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.89 per share and the total transaction amounting to $164,450.00.
- On 2/20/2018 Phillip G Febbo, Insider, sold 4,942 with an average share price of $32.84 per share and the total transaction amounting to $162,295.28.
Recent Trading Activity for NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Shares of NASDAQ:GHDX – Genomic Health closed the previous trading session at 44.08 up +4.40 11.07% with 179562 shares trading hands.